Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 51,499 Rapport Therapeutics, Inc. shares (Form 4)

Traded Aug 10 to Aug 11, 2026 · Filed Aug 12, 2026

From Aug 10 to Aug 11, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 51,499 Rapport Therapeutics, Inc. shares at an average US$47.24 for US$2.43M under a trading plan, leaving 486,108 shares. Filed Aug 12, 2026 (Form 4).

Sold
51,499 shares
Price
US$47.24 average (US$45.97 to US$48.62)
Value
US$2.43M
Holding after
486,108 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockSale14,171US$45.97523,436Direct
Aug 10, 2026Common StockSale8,370US$46.75515,066Direct
Aug 11, 2026Common StockSale3,664US$46.90511,402Direct
Aug 11, 2026Common StockSale19,500US$48.04491,902Direct
Aug 11, 2026Common StockSale5,794US$48.62486,108Direct

Source

View original at SEC

Related